New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

by Kyle B. Williams, David A. Largaespada
Published 2020-04-01

Evidence of a bacterial receptor for lysozyme: binding of lysozyme to the anti-σ factor RsiV controls activation of the ecf σ factor σV.

by Jessica L Hastie, Kyle B Williams, Carolina Sepúlveda, Jon C Houtman, Katrina T Forest, Craig D Ellermeier
Published 2014-10-01

The Anti-sigma Factor RsiV Is a Bacterial Receptor for Lysozyme: Co-crystal Structure Determination and Demonstration That Binding of Lysozyme to RsiV Is Required for σV Activation...

by Jessica L Hastie, Kyle B Williams, Lindsey L Bohr, Jon C Houtman, Lokesh Gakhar, Craig D Ellermeier
Published 2016-09-01